国药一致：2025年净利同比预增64.20%-89.11%

Core Viewpoint - The company, China National Pharmaceutical Group Corporation (国药一致), forecasts a net profit attributable to shareholders of 1.055 billion to 1.215 billion yuan for 2025, representing a year-on-year growth of 64.20% to 89.11% [1] Group 1: Financial Performance - The expected net profit for 2025 is projected to be between 1.055 billion and 1.215 billion yuan [1] - This forecast indicates a significant increase in profitability, with a growth rate ranging from 64.20% to 89.11% compared to the previous year [1] Group 2: Business Operations - The distribution business remains a cornerstone of the company's operations, continuing to show stable growth [1] - The company has enhanced its procurement system, optimized product structure, and strategically adjusted store layouts to effectively improve operational quality [1]